South and Central America Drug Modelling Software Market

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South and Central America Drug Modelling Software Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South and Central America Drug Modelling Software Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
5.1.2 Increasing Economic Burden of Drug Discovery

5.2 Market Opportunities

5.2.1 Strategic Activities by Market Players

5.3 Future Trends

5.3.1 Growing Adoption of Artificial Intelligence in Drug Discovery

5.4 Impact of Drivers and Restraints

6. South and Central America Drug Modelling Software Market Regional Analysis

6.1 South and Central America Drug Modelling Software Market Overview

6.2 South and Central America Drug Modelling Software Market Revenue 2017-2027 (US$ Million)

6.3 South and Central America Drug Modelling Software Market Forecast Analysis

7. South and Central America Drug Modelling Software Market Analysis – by Product Type

7.1 Database

7.1.1 Overview
7.1.2 Database: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Software

7.2.1 Overview
7.2.2 Software: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2031 (US$ Million)

8. South and Central America Drug Modelling Software Market Analysis – by Application

8.1 Drug Discovery and Development

8.1.1 Overview
8.1.2 Drug Discovery and Development: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Computational Physiological Medicine

8.2.1 Overview
8.2.2 Computational Physiological Medicine: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Disease Modelling

8.3.1 Overview
8.3.2 Disease Modelling: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Medical Imaging

8.4.1 Overview
8.4.2 Medical Imaging: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Predictive Analysis of Drug Targets

8.5.1 Overview
8.5.2 Predictive Analysis of Drug Targets: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

8.6 Simulation Software

8.6.1 Overview
8.6.2 Simulation Software: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

8.7 Cellular Simulation

8.7.1 Overview
8.7.2 Cellular Simulation: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

9. South and Central America Drug Modelling Software Market – South and Central America Analysis

9.1 South and Central America

9.1.1 South and Central America Drug Modelling Software Market Breakdown, by Key Country, 2020 and 2027 (%)
9.1.1.1 South and Central America Drug Modelling Software Market – Revenue and Forecast Analysis – by Country
9.1.1.1 Brazil: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.1.1 Brazil: South and Central America Drug Modelling Software Market Breakdown, by Product Type
9.1.1.1.2 Brazil: South and Central America Drug Modelling Software Market Breakdown, by Application

9.1.1.2 Argentina: South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.2.1 Argentina: South and Central America Drug Modelling Software Market Breakdown, by Product Type
9.1.1.2.2 Argentina: South and Central America Drug Modelling Software Market Breakdown, by Application

9.1.1.3 Rest of South and Central America : South and Central America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.3.1 Rest of South and Central America : South and Central America Drug Modelling Software Market Breakdown, by Product Type
9.1.1.3.2 Rest of South and Central America : South and Central America Drug Modelling Software Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. South and Central America Drug Modelling Software Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Crown Bioscience Inc (JSR life science)

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Compugen Ltd.

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Biognos AB

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Dassault Syst?mes

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Acellera

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights